Layla Barrera, DO
Internal Medicine · Stony Brook, NYNPI 1447788575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $392 and has fallen 71.8% since, to $111 in 2024.
Across 47 payments — averaging $19.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$136
- Merck$101
- Boehringer Ingelheim$94
- Amarin Pharma, Inc.$85
- Amgen$73
- Daiichi Sankyo Inc.$72
- plus $372 from 12 others
What the payments were for
- Food & beverage$933100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 7 | $136 |
| Merck | 6 | $101 |
| Boehringer Ingelheim | 4 | $94 |
| Amarin Pharma, Inc. | 4 | $85 |
| Amgen | 3 | $73 |
| Daiichi Sankyo Inc. | 4 | $72 |
| AbbVie | 4 | $70 |
| Lilly USA, LLC | 3 | $69 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Novartis | 2 | $32 |
| Johnson & Johnson | 1 | $25 |
| Exact Sciences | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Shield Therapeutics Inc | 1 | $22 |
| Novo Nordisk | 1 | $21 |
| Si-bone, Inc. | 1 | $20 |
| Pfizer | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $15 |
How this compares
$933 in reported general payments places this provider in the 70th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Stony Brook
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.